Saudi German Health and PaxeraHealth Advanced AI-Driven Sports Medicine Research at RSNA 2025
Chicago, USA / Cairo, Egypt — PaxeraHealth and Saudi German Health announced a significant joint milestone in AI-powered sports medicine research and global scientific leadership during the Radiological Society of North America Annual Meeting (RSNA) 2025, held in Chicago from November 30 to December 4, 2025.
The Radiology Department at Saudi German Hospital Cairo, through its Sports Injuries Diagnostic Unit, achieved the acceptance of two scientific abstracts at RSNA 2025—demonstrating the successful convergence of clinical expertise, long-term research investment, and AI-native enterprise imaging technologies.
Central to this collaboration is ARK, PaxeraHealth’s advanced AI orchestration and development platform, engineered to convert complex clinical and imaging data into scalable, real-world AI solutions. ARK enables healthcare organizations to curate large-scale datasets, manage imaging and clinical metadata, develop and validate AI models, and securely deploy them across enterprise imaging environments within a governed and scalable framework.
Within this initiative, ARK was utilized to curate one of the region’s most comprehensive sports injury imaging datasets, support AI-driven musculoskeletal injury analysis, enhance reporting depth and consistency, and enable research-grade model development. The work establishes a foundation for evidence-based time to return-to-play (RTP) guidance for professional athletes especially football players following injury.
The accepted research focuses on novel application of AI-enhanced classification of muscle injuries, illustrating the potential role of how enterprise-level AI platforms can significantly improve diagnostic accuracy, reporting analytics, and clinical decision-making through prediction of time to return-to-play (RTP) —advancing the future of sports medicine on a global scale.
This innovation demonstrated international impact and global recognition helping to optimize return-to-play timelines, reduce the risk of re-injury and individualize rehabilitation programs directly improving outcomes and clinical decision-making for elite athletes, representing a true shift of AI from theory into the potential of high impact clinical practice in sports medicine.
One abstract will be presented by Prof. Dr. Yasser A. Abd El Fattah, Radiology Director & Senior Consultant at Saudi German Health Egypt, while the second has been selected for oral presentation by Prof. Dr. Sherif El Hennawy, Radiology Senior Consultant, underscoring the scientific rigor and international relevance of the research.
This milestone represents the outcome of a decade-long research journey at Saudi German Hospital Cairo, combining sustained clinical excellence, data stewardship, and innovation with PaxeraHealth’s AI-native enterprise imaging technologies.
Together, Saudi German Health and PaxeraHealth reaffirm their shared commitment to advancing AI-powered enterprise imaging, research excellence, and clinically meaningful innovation—driving improved patient outcomes and shaping the future of sports medicine across Egypt, the Middle East, and beyond
About Saudi German Health
Saudi German Health is one of the leading healthcare groups in the Middle East and North Africa, delivering advanced, patient-centric care supported by education, research, and innovation, with a strong commitment to clinical excellence and quality outcomes.
About PaxeraHealth
PaxeraHealth is a global provider of AI-native enterprise imaging solutions, offering advanced PACS, VNA, and AI platforms—including ARK—to enable intelligent imaging workflows, scalable AI adoption, and improved clinical outcomes through optimized data management and workflow efficiency
